Shenzhen Glory Medical Co (002551) Fair Value & Analysis
Healthcare · CN · Market cap 2.4B CNY
Fair value as of: Jun 25, 2026
Analysis
Shenzhen Glory Medical Co (002551) currently trades at ¥2.83, while our model-based Fair Value estimate is ¥0.7600 — implying the stock looks roughly 73.1% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Shenzhen Glory Medical Co.,Ltd. offers hospital construction and medical system integrated solutions in China and internationally. It operates through Medical Products, Medical Services, and Health Industry segments. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering projects; and medical software development activities. It also sells medical information solutions comprising digital operating rooms, surgical teaching systems, remote surgical consultation, mobile digital video station, central management platforms, and digital pre-hospital emergency platforms. In addition, the company provides medical protective equipment, including non-woven medical surgical gown and bag, medical disposable protective clothing, and disposable isolation gowns, as well as medical disposable masks; and medical consumables. Further, the company provides professional hospital digital solutions…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Shenzhen Glory Medical Co (002551) undervalued?
What is the fair value of 002551?
What is the quality score of 002551?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.